| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 113,463 | 111,989 | 105,088 | 113,132 | | Cost of Revenue | 67,957 | 69,055 | 71,994 | 80,539 | | | Gross Profit | 45,506 | 42,934 | 33,094 | 32,593 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 26,563 | 31,774 | 33,901 | 40,155 | | Non Recurring | 1,328 | 1,637 | 817 | 61,578 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 17,615 | 9,523 | (1,624) | (69,140) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 124 | 30 | 70 | 90 | | Earnings Before Interest And Taxes | 17,739 | 9,553 | (1,554) | (69,050) | | Interest Expense | 2,880 | 2,468 | 1,449 | 1,753 | | Income Before Tax | 14,859 | 7,085 | (3,003) | (70,803) | | Income Tax Expense | 1,553 | 2,317 | (707) | (12,025) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 13,306 | 4,768 | (2,296) | (58,778) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 412 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 13,306 | 4,768 | (2,296) | (58,366) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $13,306 | $4,768 | ($2,296) | ($58,366) |
|
0.16% Nasdaq 
Income Statement
